Prevalence and Risk Factors of Chronic Urticaria in China: A Nationwide Cross‐sectional Study
Xiao Zhang,Xiaoting Song,Mei Zhang,Chun Li,Zhengjing Huang,Bo Liu,Yu Miao,Shuanglu Liao,Tingting Luan,Torsten Zuberbier,Marcus Maurer,Zuotao Zhao,Limin Wang
DOI: https://doi.org/10.1111/all.15287
IF: 12.4
2022-01-01
Allergy
Abstract:AllergyVolume 77, Issue 7 p. 2233-2236 LETTER Prevalence and risk factors of chronic urticaria in China: A nationwide cross-sectional study Xiao Zhang, Xiao Zhang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorXiaoting Song, Xiaoting Song orcid.org/0000-0002-2268-4402 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorMei Zhang, Mei Zhang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorChun Li, Chun Li National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorZhengjing Huang, Zhengjing Huang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorBo Liu, Bo Liu Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorMiao Yu, Miao Yu orcid.org/0000-0003-0228-7888 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorShuanglu Liao, Shuanglu Liao Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorTingting Luan, Tingting Luan Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorTorsten Zuberbier, Torsten Zuberbier orcid.org/0000-0002-1466-8875 Search for more papers by this authorMarcus Maurer, Marcus Maurer orcid.org/0000-0002-4121-481X Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology, Venereology and Allergy, Charité – Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorZuotao Zhao, Corresponding Author Zuotao Zhao zhaozuotaotao@163.com orcid.org/0000-0002-9595-6050 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China Correspondence Zuotao Zhao, Department of Dermatology and Venereology, Peking University First Hospital, Xishiku Avenue No. 8, Beijing, China. Email: zhaozuotaotao@163.com Limin Wang, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China. Email: wanglimin@ncncd.chinacdc.cnSearch for more papers by this authorLimin Wang, Corresponding Author Limin Wang wanglimin@ncncd.chinacdc.cn National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China Correspondence Zuotao Zhao, Department of Dermatology and Venereology, Peking University First Hospital, Xishiku Avenue No. 8, Beijing, China. Email: zhaozuotaotao@163.com Limin Wang, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China. Email: wanglimin@ncncd.chinacdc.cnSearch for more papers by this author Xiao Zhang, Xiao Zhang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorXiaoting Song, Xiaoting Song orcid.org/0000-0002-2268-4402 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorMei Zhang, Mei Zhang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorChun Li, Chun Li National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorZhengjing Huang, Zhengjing Huang National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaSearch for more papers by this authorBo Liu, Bo Liu Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorMiao Yu, Miao Yu orcid.org/0000-0003-0228-7888 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorShuanglu Liao, Shuanglu Liao Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorTingting Luan, Tingting Luan Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, ChinaSearch for more papers by this authorTorsten Zuberbier, Torsten Zuberbier orcid.org/0000-0002-1466-8875 Search for more papers by this authorMarcus Maurer, Marcus Maurer orcid.org/0000-0002-4121-481X Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology, Venereology and Allergy, Charité – Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorZuotao Zhao, Corresponding Author Zuotao Zhao zhaozuotaotao@163.com orcid.org/0000-0002-9595-6050 Department of Dermatology and Venerology, Peking University First Hospital; National Clinical Research Center for Skin and Immune Diseases; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses; NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China Correspondence Zuotao Zhao, Department of Dermatology and Venereology, Peking University First Hospital, Xishiku Avenue No. 8, Beijing, China. Email: zhaozuotaotao@163.com Limin Wang, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China. Email: wanglimin@ncncd.chinacdc.cnSearch for more papers by this authorLimin Wang, Corresponding Author Limin Wang wanglimin@ncncd.chinacdc.cn National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China Correspondence Zuotao Zhao, Department of Dermatology and Venereology, Peking University First Hospital, Xishiku Avenue No. 8, Beijing, China. Email: zhaozuotaotao@163.com Limin Wang, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China. Email: wanglimin@ncncd.chinacdc.cnSearch for more papers by this author First published: 24 March 2022 https://doi.org/10.1111/all.15287 Xiao Zhang, Xiaoting Song, and Mei Zhang contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat CONFLICT OF INTEREST Dr. Zhao is the speaker/advisor for and/or has received research funding from Novartis, Pfizer, Astellas, Galderma, Janssen, GSK, BAYER, LEO, MEDA Pharma, and ALK Pharma, outside the submitted work. Dr. Zuberbier reports personal fees from Bayer Health Care, FAES, Novartis, Henkel, Novartis, Henkel, AstraZeneca Fee for talk, AbbVie Fee for talk, ALK Fee for talk, Almirall Fee for talk, Astellas Fee for talk, Bayer Health Care Fee for talk, Bencard Fee for talk, Berlin Chemie Fee for talk, FAES Fee for talk, HAL Fee for talk, Leti Fee for talk, Meda Fee for talk, Menarini Fee for talk, Merck Fee for talk, MSD Fee for talk, Novartis Fee for talk, Pfizer Fee for talk, Sanofi Fee for talk, Stallergenes Fee for talk, Takeda Fee for talk, Teva Fee for talk, UCB Fee for talk, Henkel Fee for talk, Kryolan Fee for talk, L'Oréal Fee for talk, all outside the submitted work. Dr. Maurer is the speaker/advisor for and/or has received research funding from Allakos, Alnylam, Amgen, Aralez, ArgenX, AstraZeneca, BioCryst, Blueprint, Celldex, Centogene, CSL Behring, Dyax, FAES, Genentech, GIInnovation, Innate Pharma, Kalvista, Kyowa Kirin, Leo Pharma, Lilly, Menarini, Moxie, Novartis, Pharming, Pharvaris, Roche, Sanofi/Regeneron, Shire/Takeda, Third HarmonicBio, UCB, and Uriach, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. Supporting Information Filename Description all15287-sup-0001-AppendixS1.docxWord 2007 document , 255.1 KB Appendix S1 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume77, Issue7July 2022Pages 2233-2236 RelatedInformation